CureVac announced a collaboration with myNEO last month to look for neoantigens on the surface of tumor cells in order to develop mRNA-based cancer vaccines.
Moderna and BioNTech, and CureVac, are known as the "mRNA Troika". However, the Phase 3 clinical trial of the mRNA COVID-19 vaccine developed by CureVac failed.
CureVac has fallen far behind Moderna and BioNTech due to the failure of the...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Greek